MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 31.07.2025
OPKO Health DSO 2011-2026 | OPK
DSO Jährlich OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 240 | 252 | 70.3 | 56.1 | 53.5 | 63.8 | 59.7 | 64 | 74.5 | 155 | 92.3 | 119 | 183 | 164 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 252 | 53.5 | 118 |
DSO Vierteljährlich OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.9 | 61.7 | 55.7 | 54.3 | 60.1 | 83.9 | 57.1 | 47.8 | - | 31.3 | 31.3 | 65.5 | 58.5 | 61.6 | 60.5 | 50.8 | 52.8 | 61 | 86.7 | 90.8 | 54.8 | 53.7 | 54.3 | 57.1 | 59.2 | 52.6 | 49.8 | 55.4 | 93.8 | 61.4 | 51.6 | 66.1 | 81.4 | 67.4 | 56.3 | 64.9 | 64 | 124 | 417 | 324 | 71.4 | 92.2 | 77.4 | 81.4 | 87.2 | 87.4 | 75.7 | 59.5 | 119 | 164 | 189 | 175 | 198 | 168 | 136 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 417 | 31.3 | 89.2 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 29.8 | -3.87 % | $ 321 M |  China |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
101 | - | - | $ 79.8 M | USA |
 |
BioNano Genomics
BNGO
|
83.4 | $ 1.13 | -3.54 % | $ 1.44 M | USA |
 |
Castle Biosciences
CSTL
|
49.2 | - | - | $ 914 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Danaher Corporation
DHR
|
57 | $ 219.93 | 0.09 % | $ 161 B | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
85 | - | - | $ 26.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 209.75 | 2.09 % | $ 23.3 B | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 19.51 | -5.18 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
85.8 | $ 11.07 | 1.37 % | $ 314 M |  Israel |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
Exact Sciences Corporation
EXAS
|
29.9 | $ 103.42 | - | $ 19.2 B | USA |
 |
Interpace Biosciences
IDXG
|
53.1 | $ 1.82 | - | $ 7.98 M | USA |
 |
Lantheus Holdings
LNTH
|
72 | $ 67.04 | - | $ 4.64 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 23.02 | - | $ 696 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | - | -0.62 % | $ 28.7 B |  Schweiz |
 |
Guardant Health
GH
|
49.2 | $ 106.6 | 1.65 % | $ 13.1 B | USA |
 |
NeoGenomics
NEO
|
77.8 | $ 11.47 | - | $ 1.45 B | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B |  Niderland |
 |
Natera
NTRA
|
81.5 | - | -0.5 % | $ 20.7 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | - | -9.16 % | $ 8.49 B | USA |
 |
IDEXX Laboratories
IDXX
|
43.6 | - | - | $ 53.5 B | USA |
 |
Illumina
ILMN
|
61.3 | $ 117.01 | -1.95 % | $ 18.6 B | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 176.27 | - | $ 32 B | USA |
|
Biodesix
BDSX
|
41.7 | - | - | $ 1.33 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
54.1 | $ 289.4 | 1.75 % | $ 24.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
7.11 | $ 3.56 | -4.56 % | $ 1.91 M | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | - | - | $ 11 B |  Irlanda |
 |
Quidel Corporation
QDEL
|
116 | - | -3.13 % | $ 1.19 B | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.23 | - | $ 5.12 M | USA |
 |
Bioventus
BVS
|
92.3 | $ 8.04 | - | $ 504 M | USA |